These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34157977)

  • 1. Primary headaches during the COVID-19 lockdown in Germany: analysis of data from 2325 patients using an electronic headache diary.
    Raffaelli B; Mecklenburg J; Scholler S; Overeem LH; Oliveira Gonçalves AS; Reuter U; Neeb L
    J Headache Pain; 2021 Jun; 22(1):59. PubMed ID: 34157977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the Evolution of Headache Among Regular Users of a Daily Electronic Diary via a Smartphone App: Observational Study.
    Raffaelli B; Mecklenburg J; Overeem LH; Scholler S; Dahlem MA; Kurth T; Oliveira Gonçalves AS; Reuter U; Neeb L
    JMIR Mhealth Uhealth; 2021 Jul; 9(7):e26401. PubMed ID: 34255716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study.
    van der Arend BWH; Bloemhof MM; van der Schoor AG; van Zwet EW; Terwindt GM
    Cephalalgia; 2023 Sep; 43(9):3331024231198792. PubMed ID: 37684012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine.
    Gonzalez-Martinez A; Planchuelo-Gómez Á; Guerrero ÁL; García-Azorín D; Santos-Lasaosa S; Navarro-Pérez MP; Odriozola-González P; Irurtia MJ; Quintas S; de Luis-García R; Gago-Veiga AB
    Pain Med; 2021 Sep; 22(9):2079-2091. PubMed ID: 33659991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triggers and clinical changes of childhood primary headache characteristics during COVID-19 pandemic lockdown.
    Dedeoglu Ö; Konuşkan B
    Acta Neurol Belg; 2023 Feb; 123(1):215-220. PubMed ID: 36478546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical Activity Behavior Before, During, and After COVID-19 Restrictions: Longitudinal Smartphone-Tracking Study of Adults in the United Kingdom.
    McCarthy H; Potts HWW; Fisher A
    J Med Internet Res; 2021 Feb; 23(2):e23701. PubMed ID: 33347421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 lockdown attack on headache emergency admissions: a multidisciplinary retrospective study.
    D'Acunto L; Pasquin F; Buoite Stella A; Olivo S; Granato A; Cominotto F; Manganotti P
    Neurol Sci; 2022 Mar; 43(3):1575-1582. PubMed ID: 34822031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children.
    Papetti L; Alaimo Di Loro P; Tarantino S; Grazzi L; Guidetti V; Parisi P; Raieli V; Sciruicchio V; Termine C; Toldo I; Tozzi E; Verdecchia P; Carotenuto M; Battisti M; Celi A; D'Agnano D; Faedda N; Ferilli MA; Grillo G; Natalucci G; Onofri A; Pelizza MF; Ursitti F; Vasta M; Velardi M; Balestri M; Moavero R; Vigevano F; Valeriani M
    Cephalalgia; 2020 Nov; 40(13):1459-1473. PubMed ID: 33146039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown.
    Gonzalez-Martinez A; Planchuelo-Gómez Á; Guerrero ÁL; García-Azorín D; Santos-Lasaosa S; Navarro-Pérez MP; Odriozola-González P; Irurtia MJ; Quintas S; de Luis-García R; Gago-Veiga AB
    Neurol Sci; 2021 Dec; 42(12):5087-5092. PubMed ID: 33768436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic migraine in the first COVID-19 lockdown: the impact of sleep, remote working, and other life/psychological changes.
    Currò CT; Ciacciarelli A; Vitale C; Vinci ES; Toscano A; Vita G; Trimarchi G; Silvestri R; Autunno M
    Neurol Sci; 2021 Nov; 42(11):4403-4418. PubMed ID: 34365547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Internet-based study on the impact of COVID-19 pandemic-related lockdown on migraine in India.
    Chowdhury D; Krishnan A; Duggal A; Datta D; Mundra A; Deorari V; Tomar A; Koul A
    Acta Neurol Scand; 2021 Dec; 144(6):706-716. PubMed ID: 34459497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the COVID-19 pandemic on migraine in Japan: a multicentre cross-sectional study.
    Suzuki K; Takeshima T; Igarashi H; Imai N; Danno D; Yamamoto T; Nagata E; Haruyama Y; Mitsufuji T; Suzuki S; Ito Y; Shibata M; Kowa H; Kikui S; Shiina T; Okamura M; Tatsumoto M; Hirata K
    J Headache Pain; 2021 Jun; 22(1):53. PubMed ID: 34098873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lockdown during COVID-19 on migraine: A longitudinal cohort study.
    Verhagen IE; van Casteren DS; de Vries Lentsch S; Terwindt GM
    Cephalalgia; 2021 Jun; 41(7):865-870. PubMed ID: 33430642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndromic Surveillance Insights from a Symptom Assessment App Before and During COVID-19 Measures in Germany and the United Kingdom: Results From Repeated Cross-Sectional Analyses.
    Mehl A; Bergey F; Cawley C; Gilsdorf A
    JMIR Mhealth Uhealth; 2020 Oct; 8(10):e21364. PubMed ID: 32997640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of Coronavirus disease 2019 (COVID-19) pandemic on migraine disorder.
    Haghdoost F; Carcel C; Chandrasekhar D; Rodgers A; Delcourt C
    J Neurol; 2021 Dec; 268(12):4429-4435. PubMed ID: 33950336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a smartphone application for self-rehabilitation after anterior cruciate ligament reconstruction during a COVID-19 lockdown.
    Bauwens PH; Fayard JM; Tatar M; Abid H; Freychet B; Sonnery-Cottet B; Thaunat M
    Orthop Traumatol Surg Res; 2023 Feb; 109(1):103342. PubMed ID: 35660080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials.
    Tepper SJ; Ashina M; Reuter U; Hallström Y; Broessner G; Bonner JH; Picard H; Cheng S; Chou DE; Zhang F; Klatt J; Mikol DD
    J Headache Pain; 2021 Jul; 22(1):81. PubMed ID: 34301173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle impact on migraine during home confinement.
    Granato A; Furlanis G; D'Acunto L; Olivo S; Buoite Stella A; Manganotti P
    Acta Neurol Belg; 2022 Apr; 122(2):497-503. PubMed ID: 35146703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.